XML 33 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Supplementary Financial Information
 12 Months Ended
Oct. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplementary Financial Information Supplementary Financial Information
Cash, cash equivalents and restricted cash
 As of October 31
 20252024
 In millions
Cash and cash equivalents$3,690 $3,238 
Restricted cash(1)
15 15 
$3,705 $3,253 
(1)    Restricted Cash is related to amounts collected and held on behalf of a third-party for trade receivables previously sold.
Accounts Receivable
The allowance for credit losses related to accounts receivable and changes were as follows:
 For the fiscal years ended October 31
 202520242023
 In millions
Balance at beginning of period$83 $93 $107 
Current-period allowance for credit losses8 3 (2)
Deductions, net of recoveries(8)(13)(12)
Balance at end of period$83 $83 $93 
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Consolidated Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from the similar transactions and reported as a current liability in the Consolidated Balance Sheets. The recourse obligations as of October 31, 2025 and 2024 were not material.
The following is a summary of the activity under these arrangements:
 For the fiscal years ended October 31
 202520242023
 In millions
Balance at beginning of year(1)
$284 $141 $185 
Trade receivables sold11,830 12,200 13,391 
Cash receipts(12,006)(12,063)(13,449)
Foreign currency and other9 6 14 
Balance at end of year(1)
$117 $284 $141 
(1)    Amounts outstanding from third parties reported in Accounts Receivable in the Consolidated Balance Sheets.
Inventory
 As of October 31
 20252024
 In millions
Finished goods$4,721 $4,338 
Purchased parts and fabricated assemblies3,791 3,382 
$8,512 $7,720 
Other Current Assets
As of October 31
 20252024
 In millions
Supplier and other receivables
$1,981 $2,180 
Prepaid and other current assets
1,577 1,462 
Value-added taxes receivable986 1,028 
$4,544 $4,670 

Property, Plant and Equipment, Net
 As of October 31
 20252024
 In millions
Land, buildings and leasehold improvements$2,619 $2,527 
Machinery and equipment, including equipment held for lease5,867 5,465 
8,486 7,992 
Accumulated depreciation(5,437)(5,078)
$3,049 $2,914 
Depreciation expense was $523 million, $501 million and $491 million in fiscal years 2025, 2024 and 2023, respectively.
Other Non-Current Assets
 As of October 31
 20252024
 In millions
Deferred tax assets
$3,318 $3,311 
Intangible assets
1,012 1,319 
Right-of-use assets
1,129 1,165 
Prepaid pension and post-retirement benefit assets
425 362 
Deposits and prepaid
316 322 
Other1,361 1,129 
 $7,561 $7,608 
Other Current Liabilities
 As of October 31
 20252024
 In millions
Sales and marketing programs$3,103 $3,060 
Deferred revenue1,609 1,446 
Other accrued taxes
1,258 1,233 
Employee compensation and benefit
965 970 
Warranty401 486 
Operating lease liabilities
401 443 
Tax liability297 291 
Other2,328 2,449 
 $10,362 $10,378 

Other Non-Current Liabilities
 As of October 31
 20252024
 In millions
Deferred revenue$1,632 $1,487 
Tax liability496 839 
Operating lease liabilities
815 787 
Pension, post-retirement, and post-employment liabilities
564 607 
Deferred tax liability16 31 
Other513 531 
 $4,036 $4,282 

Interest and Other, Net
 For the fiscal years ended October 31
 202520242023
 In millions
Interest expense on borrowings$(430)$(452)$(548)
Factoring costs
(125)(155)(136)
Certain litigation benefits
52 — — 
Net (loss) gain on debt extinguishment
— (3)107 
Non-operating retirement-related credits13 14 51 
Other, net(16)57 7 
 $(506)$(539)$(519)
Net Revenue by Region
 For the fiscal years ended October 31
 202520242023
 In millions
Americas$23,545 $23,251 $23,095 
Europe, Middle East and Africa18,596 18,044 17,819 
Asia-Pacific and Japan13,154 12,264 12,804 
Total net revenue$55,295 $53,559 $53,718 
Value of Remaining Performance Obligations
As of October 31, 2025, the estimated value of transaction price allocated to remaining performance obligations was $4.3 billion. HP expects to recognize approximately $1.9 billion of the unearned amount in next 12 months and $2.4 billion thereafter.
HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if:
•the contract has an original expected duration of one year or less; or
•the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or
•the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation.
The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency.
Costs of Obtaining Contracts and Fulfillment Cost
As of October 31, 2025, deferred contract fulfillment and acquisition costs balances were $33 million and $42 million, respectively, included in Other current assets and Other non-current assets in the Consolidated Balance Sheets. During the fiscal year ended October 31, 2025, the Company amortized $68 million of these costs.
As of October 31, 2024, deferred contract fulfillment and acquisition costs balances were $36 million and $50 million, respectively, included in Other current assets and Other non-current assets in the Consolidated Balance Sheets. During the fiscal year ended October 31, 2024, the Company amortized $86 million of these costs.
Contract Liabilities
As of October 31, 2025 and 2024, HP’s contract liabilities balances were $3.2 billion and $2.9 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Consolidated Balance Sheets.
The increase in the contract liabilities balance for fiscal year 2025 was primarily driven by sales of fixed-price support and maintenance services, partially offset by $1.5 billion of revenue recognized that were included in the contract liabilities balance as of October 31, 2024.
As of October 31, 2024 and 2023, HP’s contract liabilities balances were $2.9 billion and $2.7 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Consolidated Balance Sheets.
The increase in the contract liabilities balance for fiscal year 2024 was primarily driven by sales of fixed-price support and maintenance services, partially offset by $1.4 billion of revenue recognized that were included in the contract liabilities balance as of October 31, 2023.
Supplier Finance Programs
HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under these programs, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs have no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. For certain programs, HP pays a monthly service fee to a third-party administrator that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of October 31, 2025 and October 31, 2024, HP had $8.9 billion and $7.8 billion, respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs. These obligations are included within the Accounts payable line item of HP’s Consolidated Balance Sheets. As of both October 31, 2025 and October 31, 2024 the Company’s outstanding payment obligations that suppliers elected to sell to participating financial institutions were $0.1 billion.
The following table is a rollforward of the obligations confirmed under the program for fiscal year 2025:
 2025
 In millions
Confirmed obligations outstanding at the beginning of the year
$7,808 
Invoices confirmed during the year
44,022 
Confirmed invoices paid during the year
(42,921)
Foreign currency translation
4 
Confirmed obligations outstanding at the end of the year
$8,913 
Government Assistance
HP receives assistance under legally enforceable agreements with governments in support of certain business activities, including expansion of operations, production or shipment of products from specific jurisdictions, research and development etc. These grants are generally received in the form of cash and require compliance with certain conditions specified in each grant agreement. The duration of the grant agreements are usually for a period of three to five years.
HP recognized $196 million, $126 million and $117 million of government assistance in the Consolidated Statement of Earnings in fiscal year 2025, 2024, and 2023, respectively, of which $130 million, $111 million and $95 million, respectively, was reported as a reduction of Cost of net revenue.